427 related articles for article (PubMed ID: 15776112)
21. Down-regulation of lipid raft-associated onco-proteins via cholesterol-dependent lipid raft internalization in docosahexaenoic acid-induced apoptosis.
Lee EJ; Yun UJ; Koo KH; Sung JY; Shim J; Ye SK; Hong KM; Kim YN
Biochim Biophys Acta; 2014 Jan; 1841(1):190-203. PubMed ID: 24120917
[TBL] [Abstract][Full Text] [Related]
22. Lipid rafts couple store-operated Ca2+ entry to constitutive activation of PKB/Akt in a Ca2+/calmodulin-, Src- and PP2A-mediated pathway and promote melanoma tumor growth.
Fedida-Metula S; Feldman B; Koshelev V; Levin-Gromiko U; Voronov E; Fishman D
Carcinogenesis; 2012 Apr; 33(4):740-50. PubMed ID: 22287561
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PCc-3 prostate cancer cells.
Beresford SA; Davies MA; Gallick GE; Donato NJ
J Interferon Cytokine Res; 2001 May; 21(5):313-22. PubMed ID: 11429162
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway.
Li Y; Sarkar FH
Clin Cancer Res; 2002 Jul; 8(7):2369-77. PubMed ID: 12114442
[TBL] [Abstract][Full Text] [Related]
25. Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression.
Kochuparambil ST; Al-Husein B; Goc A; Soliman S; Somanath PR
J Pharmacol Exp Ther; 2011 Feb; 336(2):496-505. PubMed ID: 21059805
[TBL] [Abstract][Full Text] [Related]
26. Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling.
Khanzada UK; Pardo OE; Meier C; Downward J; Seckl MJ; Arcaro A
Oncogene; 2006 Feb; 25(6):877-87. PubMed ID: 16170339
[TBL] [Abstract][Full Text] [Related]
27. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.
Yang L; Dan HC; Sun M; Liu Q; Sun XM; Feldman RI; Hamilton AD; Polokoff M; Nicosia SV; Herlyn M; Sebti SM; Cheng JQ
Cancer Res; 2004 Jul; 64(13):4394-9. PubMed ID: 15231645
[TBL] [Abstract][Full Text] [Related]
28. Ganglioside loss promotes survival primarily by activating integrin-linked kinase/Akt without phosphoinositide 3-OH kinase signaling.
Sun P; Wang XQ; Lopatka K; Bangash S; Paller AS
J Invest Dermatol; 2002 Jul; 119(1):107-17. PubMed ID: 12164932
[TBL] [Abstract][Full Text] [Related]
29. Cholesterol and prostate cancer.
Freeman MR; Solomon KR
J Cell Biochem; 2004 Jan; 91(1):54-69. PubMed ID: 14689582
[TBL] [Abstract][Full Text] [Related]
30. Regulation of protein kinase B/Akt activity and Ser473 phosphorylation by protein kinase Calpha in endothelial cells.
Partovian C; Simons M
Cell Signal; 2004 Aug; 16(8):951-7. PubMed ID: 15157674
[TBL] [Abstract][Full Text] [Related]
31. Tirucallic acids are novel pleckstrin homology domain-dependent Akt inhibitors inducing apoptosis in prostate cancer cells.
Estrada AC; Syrovets T; Pitterle K; Lunov O; Büchele B; Schimana-Pfeifer J; Schmidt T; Morad SA; Simmet T
Mol Pharmacol; 2010 Mar; 77(3):378-87. PubMed ID: 20018812
[TBL] [Abstract][Full Text] [Related]
32. CH-ILKBP regulates cell survival by facilitating the membrane translocation of protein kinase B/Akt.
Fukuda T; Guo L; Shi X; Wu C
J Cell Biol; 2003 Mar; 160(7):1001-8. PubMed ID: 12654898
[TBL] [Abstract][Full Text] [Related]
33. Cholesterol affects gene expression of the Jun family in colon carcinoma cells using different signaling pathways.
Scheinman EJ; Rostoker R; Leroith D
Mol Cell Endocrinol; 2013 Jul; 374(1-2):101-7. PubMed ID: 23643895
[TBL] [Abstract][Full Text] [Related]
34. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
Chandrasekher G; Sailaja D
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065
[TBL] [Abstract][Full Text] [Related]
35. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors.
Sinha D; Wang Z; Ruchalski KL; Levine JS; Krishnan S; Lieberthal W; Schwartz JH; Borkan SC
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F703-13. PubMed ID: 15572521
[TBL] [Abstract][Full Text] [Related]
36. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
37. Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways.
Kraus S; Levy G; Hanoch T; Naor Z; Seger R
Cancer Res; 2004 Aug; 64(16):5736-44. PubMed ID: 15313914
[TBL] [Abstract][Full Text] [Related]
38. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
Bemis DL; Capodice JL; Desai M; Buttyan R; Katz AE
Clin Cancer Res; 2004 Aug; 10(15):5282-92. PubMed ID: 15297432
[TBL] [Abstract][Full Text] [Related]
39. Critical role for lipid raft-associated Src kinases in activation of PI3K-Akt signalling.
Arcaro A; Aubert M; Espinosa del Hierro ME; Khanzada UK; Angelidou S; Tetley TD; Bittermann AG; Frame MC; Seckl MJ
Cell Signal; 2007 May; 19(5):1081-92. PubMed ID: 17275257
[TBL] [Abstract][Full Text] [Related]
40. Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells.
Kim J; Adam RM; Solomon KR; Freeman MR
Endocrinology; 2004 Feb; 145(2):613-9. PubMed ID: 14563701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
